Therapeutics
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
| PAR-23-238 | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | HHS-NIH11 | 07/19/2023 | 09/07/2026 |
| PAR-23-239 | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | HHS-NIH11 | 07/19/2023 | 09/07/2026 |
| RFA-TR-23-016 | Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 07/05/2023 | 06/02/2025 |
| PAR-24-025 | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 06/30/2023 | 09/07/2026 |
| PAR-24-024 | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/30/2023 | 09/07/2026 |
| PAR-23-200 | NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 06/27/2023 | 03/16/2025 |
| PAR-23-205 | NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) | HHS-NIH11 | 06/27/2023 | 03/16/2025 |
| PAR-24-210 | Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) | HHS-NIH11 | 06/20/2023 | 05/18/2026 |
| PAR-23-193 | Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) | HHS-NIH11 | 05/19/2023 | 04/03/2026 |
| PAR-23-177 | Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) | HHS-NIH11 | 05/11/2023 | 06/19/2025 |
| PAR-23-191 | HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) | HHS-NIH11 | 05/10/2023 | 12/08/2025 |
| RFA-NS-23-028 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) | HHS-NIH11 | 04/27/2023 | 06/09/2025 |
| PAR-23-105 | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | HHS-NIH11 | 01/13/2023 | 05/07/2025 |
| PAR-23-091 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/06/2023 | 09/07/2025 |
| PAR-23-065 | NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) | HHS-NIH11 | 11/23/2022 | 01/07/2026 |
| PAR-23-041 | Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 11/01/2022 | 07/28/2025 |
| RFA-NS-23-003 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) | HHS-NIH11 | 08/01/2022 | 06/09/2025 |
| PAR-22-216 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | HHS-NIH11 | 07/14/2022 | 07/01/2025 |
| PAR-22-189 | Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) | HHS-NIH11 | 07/12/2022 | 09/11/2025 |
| PAR-22-170 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 07/07/2022 | 09/07/2025 |
| PAR-22-185 | Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) | HHS-NIH11 | 05/27/2022 | 01/17/2025 |
| PAR-22-139 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-086 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-085 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-111 | Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 02/04/2022 | 01/07/2025 |
| PAR-22-082 | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | HHS-NIH11 | 02/03/2022 | 05/07/2025 |
| RFA-HL-23-010 | Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| RFA-HL-23-011 | Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| RFA-HL-23-012 | Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| RFA-NS-22-034 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/07/2022 | 12/06/2024 |
| PAR-22-031 | Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) | HHS-NIH11 | 11/29/2021 | 01/07/2025 |
| PAR-22-032 | Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) | HHS-NIH11 | 11/17/2021 | 01/07/2025 |